| Gene symbol | SDC1 | Synonyms | CD138, SDC, SYND1, syndecan | Type of gene | protein-coding |
| Chromosome | 2 | Map location | 2p24.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | syndecan 1 | ||||
| GTO ID | GTC0731 |
| Trial ID | ChiCTR1800015229 |
| Disease | Multiple Myeloma |
| Altered gene | CD138 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD138 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Clinical application of chimeric antigen receptor T cells in the treatment of CD138 positive relapsed and refractory multiple myeloma |
| Year | 2018 |
| Country | China |
| Company sponsor | The Second Affiliated Hospital of Soochow University |
| Cohort 1 | |||||||
|
|||||||